Recursion Pharmaceuticals (RXRX) Earnings Analysis
Recursion Pharmaceuticals (RXRX) has no confirmed upcoming earnings date. Last quarter (2025-05-05) it missed with EPS -0.5 USD vs -0.44 USD est (-13.6%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -2.48.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RXRX next report earnings?
No confirmed upcoming earnings date is currently scheduled for RXRX. This page updates as the calendar is published.
RXRX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-05-05 | -0.5 USD | -0.44 USD | -13.6% | Miss |
| 2025-02-28 | -0.53 USD | -0.44 USD | -20.5% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
RXRX valuation and analyst view
| Trailing P/E | -2.48 |
|---|---|
| Trailing EPS | -1.05757 USD |
| Price / book | 1.54 |
| Dividend yield | 0.00% |
| Market cap | 1.34B |
| Analyst consensus | Hold (4 buy / 6 hold / 0 sell) |
| Avg price target | 5.5 USD |
Related research pages
Frequently asked questions
When is Recursion Pharmaceuticals (RXRX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for RXRX. This page updates as the calendar is published.
Did RXRX beat earnings last quarter?
In its 2025-05-05 report, RXRX posted EPS of -0.5 USD versus a -0.44 USD estimate — a miss of 13.6%.
What is RXRX's earnings track record?
Over the last 2 reported quarters with consensus data, RXRX beat estimates 0 times (0%).
What is RXRX's current P/E ratio and EPS?
RXRX trades at a trailing P/E of -2.48 on trailing EPS of -1.0575737514191845 USD.
What do analysts rate RXRX?
Analyst consensus is "Hold" across 10 ratings (0 strong buy, 4 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 5.5 USD.